1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [b8bb1195-82ed-4203-b670-271eb3a53196] => Array ( [runtime-id] => b8bb1195-82ed-4203-b670-271eb3a53196 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [117f9863-0d8a-46d9-bbb4-0db52fba5098] => Array ( [runtime-id] => 117f9863-0d8a-46d9-bbb4-0db52fba5098 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;0db9f3c1dff82f715c98d33b5a2fafce0c8448cb ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [b8bb1195-82ed-4203-b670-271eb3a53196] => Array ( [runtime-id] => b8bb1195-82ed-4203-b670-271eb3a53196 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [117f9863-0d8a-46d9-bbb4-0db52fba5098] => Array ( [runtime-id] => 117f9863-0d8a-46d9-bbb4-0db52fba5098 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;0db9f3c1dff82f715c98d33b5a2fafce0c8448cb ) ) )Table 1:Patient demographic characteristics and details regarding type of MR examination, exposure to gadobenate dimeglumine, and sedation during examination
Demographic Overall 0 to <1 Month 1 to <6 Months 6 to <12 Months 12–24 Months No. of subjects 90 13 23 19 35 Male/female 48:42 4:9 11:12 16:3 17:18 Age (mo) Mean 9.7 ± 7.5 0.3 ± 0.3 3.0 ± 1.3 9.1 ± 1.8 17.9 ± 3.1 Range 0.1–23.3 0.1–0.8 1.1–5.6 6.0–11.5 12.2–23.3 Weight (Kg) Mean 7.9 ± 3.3 3.5 ± 0.7 5.4 ± 1.5 8.6 ± 1.8 10.8 ± 2.0 Range 2.3–16.3 2.3–4.8 2.6–9.6 5.2–12.1 7.4–16.3 Height (cm) Mean 68.4 ± 13.5 46.4 ± 6.7 59.4 ± 6.4 68.7 ± 5.2 81.0 ± 5.8 Range 32–91 32–51 47–71 61–76 70–91 Type of examination Brain 83 12 23 17 31 Spine 7 1 0 2 4 Dose (mmol/kg) Mean 0.084 ± 0.015 0.092 ± 0.025 0.089 ± 0.018 0.085 ± 0.01 0.078 ± 0.006 Range 0.07–0.13 0.07–0.13 0.07–0.13 0.07–0.10 0.07–0.10 Sedation/anesthesiaa Yes 72 7 16 15 34 No 7 3 3 1 0 NA 11 3 4 3 1
Note:—NA indicates not available.
↵a Patients may have received >1 drug for sedation.